Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
STORY CONTINUES BELOW THESE SALTWIRE VIDEOS By Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast on the back of strong sales for its blockbuster cancer drug Keytruda and human papillomavirus (HPV) vaccine …